Wilson Mark Andrew - Insider Non-Derivative Transactions at NEKTAR THERAPEUTICS (NKTR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 25, 2025, Wilson Mark Andrew's relationship to NEKTAR THERAPEUTICS (NKTR) is Officer (Chief Legal Officer), and currently has 21,585 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NKTR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Wilson Mark Andrew - Insider Non-Derivative Transactions of NKTR Common Stock

Wilson Mark Andrew - Insider Non-Derivative Transactions at NKTR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 26, 2025	Sell -- (Common Stock)	630	54.28	21585
Nov 22, 2025	Acquisition -- (Common Stock)	1903	0	22215
Aug 20, 2025	Sell -- (Common Stock)	676	26.59	20312
May 20, 2025	Sell -- (Common Stock)	9996	0.67	314296
Feb 20, 2025	Sell -- (Common Stock)	11040	1.01	324292
Dec 25, 2024	Sell -- (Common Stock)	16560	0.89	335332
Dec 24, 2024	Sell -- (Common Stock)	33402	0.9	351892
Dec 14, 2024	Acquisition -- (Common Stock)	165938	0	385294
Nov 20, 2024	Sell -- (Common Stock)	6407	1.01	218856
Aug 20, 2024	Sell -- (Common Stock)	5651	1.28	225263
May 18, 2024	Sell -- (Common Stock)	6260	1.75	230414
Feb 21, 2024	Sell -- (Common Stock)	7606	0.68	236674
Nov 18, 2023	Sell -- (Common Stock)	7179	0.49	243780
Aug 17, 2023	Sell -- (Common Stock)	7221	0.78	250959
May 17, 2023	Sell -- (Common Stock)	7543	0.72	257680
Feb 17, 2023	Sell -- (Common Stock)	8275	3	265223